369 related articles for article (PubMed ID: 26437207)
1. Management of periorbital basal cell carcinoma with orbital invasion.
Sun MT; Wu A; Figueira E; Huilgol S; Selva D
Future Oncol; 2015 Nov; 11(22):3003-10. PubMed ID: 26437207
[TBL] [Abstract][Full Text] [Related]
2. Orbital invasion by periocular basal cell carcinoma.
Leibovitch I; McNab A; Sullivan T; Davis G; Selva D
Ophthalmology; 2005 Apr; 112(4):717-23. PubMed ID: 15808267
[TBL] [Abstract][Full Text] [Related]
3. Recurrence Following Globe Sparing Excision for Basal Cell Carcinoma with Anterior Orbital Invasion.
Tong JY; Martin PA; Tumuluri K; Selva D
Ophthalmic Plast Reconstr Surg; 2023 Jul-Aug 01; 39(4):374-380. PubMed ID: 36852833
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
[TBL] [Abstract][Full Text] [Related]
5. Globe-sparing surgery for medial canthal Basal cell carcinoma with anterior orbital invasion.
Madge SN; Khine AA; Thaller VT; Davis G; Malhotra R; McNab A; O'Donnell B; Selva D
Ophthalmology; 2010 Nov; 117(11):2222-8. PubMed ID: 20570356
[TBL] [Abstract][Full Text] [Related]
6. Vismodegib as Eye-Sparing Neoadjuvant Treatment for Locally Advanced Periocular Basal Cell Carcinoma.
Angnardo L; Humeda Y; Alexandraki I; Wolfe CM; Cognetta AB
J Drugs Dermatol; 2021 May; 20(5):552-554. PubMed ID: 33938701
[TBL] [Abstract][Full Text] [Related]
7. Basal cell carcinoma of the eyelids and periorbital region in a Turkish population.
Soysal HG; Soysal E; Markoç F; Ardiç F
Ophthalmic Plast Reconstr Surg; 2008; 24(3):201-6. PubMed ID: 18520835
[TBL] [Abstract][Full Text] [Related]
8. Periocular Basal Cell Carcinoma Predictors for Recurrence and Infiltration of the Orbit.
Furdova A; Lukacko P
J Craniofac Surg; 2017 Jan; 28(1):e84-e87. PubMed ID: 27906855
[TBL] [Abstract][Full Text] [Related]
9. [Extremely advanced basal cell carcinoma in periocular region: a case report].
Kecik T; Ciszewska J; Bigdowska J; Mzyk M
Klin Oczna; 2000; 102(2):135-7. PubMed ID: 10932896
[TBL] [Abstract][Full Text] [Related]
10. Eyelid and ocular surface carcinoma: diagnosis and management.
Yin VT; Merritt HA; Sniegowski M; Esmaeli B
Clin Dermatol; 2015; 33(2):159-69. PubMed ID: 25704936
[TBL] [Abstract][Full Text] [Related]
11. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.
Malhotra R; Huilgol SC; Huynh NT; Selva D
Ophthalmology; 2004 Apr; 111(4):631-6. PubMed ID: 15051193
[TBL] [Abstract][Full Text] [Related]
12. Secondary Resistance to Vismodegib After Initial Successful Treatment of Extensive Recurrent Periocular Basal Cell Carcinoma with Orbital Invasion.
Papastefanou VP; René C
Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S68-S70. PubMed ID: 26398246
[TBL] [Abstract][Full Text] [Related]
13. Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma.
Sagiv O; Ding S; Ferrarotto R; Glisson B; Altan M; Johnson F; Elamin Y; Thakar SD; Nagarajan P; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2019; 35(4):350-353. PubMed ID: 30365473
[TBL] [Abstract][Full Text] [Related]
14. Identifying patients at risk for recurrent or advanced BCC.
Hamid O; Goldenberg G
J Drugs Dermatol; 2013 Nov; 12(11):1246-52; quiz 1253-4. PubMed ID: 24196332
[TBL] [Abstract][Full Text] [Related]
15. Destruction of the orbit and globe by recurrence of basal cell carcinoma.
Chew R
Optometry; 2007 Jul; 78(7):344-51. PubMed ID: 17601572
[TBL] [Abstract][Full Text] [Related]
16. Basal Cell Carcinoma Review.
Kim DP; Kus KJB; Ruiz E
Hematol Oncol Clin North Am; 2019 Feb; 33(1):13-24. PubMed ID: 30497670
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary management of advanced basal cell carcinoma: report of four cases.
Yu J; Aldabagh B; Wang J; Yom SS; El-Sayed I; Knott D; McGrath MH; Arron S;
J Drugs Dermatol; 2014 May; 13(5):601-6. PubMed ID: 24809887
[TBL] [Abstract][Full Text] [Related]
18. Histological subtypes of periocular basal cell carcinoma.
Wu A; Sun MT; Huilgol SC; Madge S; Selva D
Clin Exp Ophthalmol; 2014; 42(7):603-7. PubMed ID: 24533627
[TBL] [Abstract][Full Text] [Related]
19. Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: an expert panel consensus.
Peris K; Licitra L; Ascierto PA; Corvò R; Simonacci M; Picciotto F; Gualdi G; Pellacani G; Santoro A
Future Oncol; 2015; 11(4):703-12. PubMed ID: 25686123
[TBL] [Abstract][Full Text] [Related]
20. RECURRENT PERIOCULAR BASAL CELL CARCINOMA. CASE REPORT.
Prídavková Z; Bieliková A; Ferková N; Lysková D
Cesk Slov Oftalmol; 2021; 77(4):208-213. PubMed ID: 34507497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
